Abstract:Abstract Background Terpenoids are of high interest as chemical building blocks and pharmaceuticals. In microbes, terpenoids can be synthesized via the methylerythritol phosphate (MEP) or mevalonate (MVA) pathways. Although the MEP pathway has a higher theoretical yield, metabolic engineering has met with little success because the regulation of the pathway is poorly understood. Results We applied metabolic control analysis to the MEP pathway in Escherichia coli expressing a heterologous isoprene synthase gene ( isp S). The expression of isp S led to the accumulation of isopentenyl pyrophosphate (IPP)/dimethylallyl pyrophosphate (DMAPP) and severely impaired bacterial growth, but the coexpression of isp S and isopentenyl diphosphate isomerase ( idi ) restored normal growth and wild-type IPP/DMAPP levels. Targeted proteomics and metabolomics analysis provided a quantitative description of the pathway, which was perturbed by randomizing the ribosome binding site in the gene encoding 1-deoxyxylulose 5-phosphate synthase (Dxs). Dxs has a flux control coefficient of 0.35 (i.e., a 1% increase in Dxs activity resulted in a 0.35% increase in pathway flux) in the isoprene-producing strain and therefore exerted significant control over the flux though the MEP pathway. At higher dxs expression levels, the intracellular concentration of 2- C -methyl- d -erythritol-2,4-cyclopyrophosphate (MEcPP) increased substantially in contrast to the other MEP pathway intermediates, which were linearly dependent on the abundance of Dxs. This indicates that 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (IspG), which consumes MEcPP, became saturated and therefore limited the flux towards isoprene. The higher intracellular concentrations of MEcPP led to the efflux of this intermediate into the growth medium. Discussion These findings show the importance of Dxs, Idi and IspG and metabolite export for metabolic engineering of the MEP pathway and will facilitate further approaches for the microbial production of valuable isoprenoids.

Metabolic engineering and synthetic biology for isoprenoid production in Escherichia coli and Saccharomyces cerevisiae

Metabolic engineering and synthetic biology approaches driving isoprenoid production in Escherichia coli

Dual regulation of cytoplasmic and mitochondrial acetyl-CoA utilization for improved isoprene production in Saccharomyces cerevisiae

Engineering Microbes for Isoprene Production

Advances in Metabolic Engineering of Saccharomyces Cerevisiae for Terpenoids Biosynthesis

Combinatorial Pathway Optimization in Escherichia Coli by Directed Co‐evolution of Rate‐limiting Enzymes and Modular Pathway Engineering

Efforts Toward Industrial Biosynthesis of Isoprene

An enzymatic platform for the synthesis of isoprenoid precursors

Isoprenoid-Based Biofuels: Homologous Expression and Heterologous Expression in Prokaryotes

Combining Gal4p-mediated Expression Enhancement and Directed Evolution of Isoprene Synthase to Improve Isoprene Production in Saccharomyces Cerevisiae

Enhanced Isoprene Production by Reconstruction of Metabolic Balance Between Strengthened Precursor Supply and Improved Isoprene Synthase in Saccharomyces Cerevisiae

Cell factories for methylerythritol phosphate pathway mediated terpenoid biosynthesis: an application of modern engineering towards sustainability

Metabolic Engineering Strategies for De Novo Biosynthesis of Sterols and Steroids in Yeast.

Engineering plant family TPS into cyanobacterial host for terpenoids production

Engineering and manipulation of a mevalonate pathway in Escherichia coli for isoprene production

Engineering a universal and efficient platform for terpenoid synthesis in yeast

Identifying and engineering the ideal microbial terpenoid production host

Metabolic engineering strategies for sesquiterpene production in microorganism

Fermentation Strategies for Production of Pharmaceutical Terpenoids in Engineered Yeast

Multi-modular engineering for renewable production of isoprene via mevalonate pathway in Escherichia coli

Investigation of the methylerythritol 4-phosphate pathway for microbial terpenoid production through metabolic control analysis